Rakesh Hegde, MD
Colon & Rectal Surgery · Springfield, MONPI 1164759924
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (47.8%), food and beverage and education — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 92.5% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $3,072 and has fallen 55.7% since, to $1,360 in 2025.
Across 22 payments — averaging $221.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$5K
- Davol Inc.$196
- Acell, Inc.$89
- Innovation Technologies Inc$46
- Pacira Pharmaceuticals Incorporated$21
- Merck$12
What the payments were for
- Travel & lodging$2,33148%
- Food & beverage$1,29327%
- Education$1,25026%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 16 | $4,511 |
| Davol Inc. | 2 | $196 |
| Acell, Inc. | 1 | $89 |
| Innovation Technologies Inc | 1 | $46 |
| Pacira Pharmaceuticals Incorporated | 1 | $21 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,280
- Phasix Mesh$109
How this compares
$4,875 in reported general payments places this provider in the 55th percentile of 36 colon & rectal surgery providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sucralfate | 14 | $851 |
| Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine | 12 | $785 |
| Oxycodone Hcl | 59 | $302 |
| Metronidazole | 57 | $195 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 25 | $168 |
| Neomycin Sulfate | 42 | $160 |
| Ciprofloxacin Hcl | 11 | $73 |
| Metoclopramide Hcl | 62 | $57 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Springfield
- Megan NicolasSpringfield$6K
- John TromboldSpringfield$5K
- Jennifer LuSpringfield$5K
- Dylan CarrollSpringfield$2K
- Brian SwensonSpringfield$670
- Jose DominguezSpringfield$422
- Lawrence MendelowSaint Louis$234K
- Robert AmajoyiKansas City$56K
- Paul WiseSaint Louis$24K
- Donald SummersSaint Louis$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.